1. Home
  2. WVE vs THR Comparison

WVE vs THR Comparison

Compare WVE & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • THR
  • Stock Information
  • Founded
  • WVE 2012
  • THR 1954
  • Country
  • WVE Singapore
  • THR United States
  • Employees
  • WVE N/A
  • THR N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • THR Industrial Machinery/Components
  • Sector
  • WVE Health Care
  • THR Energy
  • Exchange
  • WVE Nasdaq
  • THR Nasdaq
  • Market Cap
  • WVE 915.6M
  • THR 829.9M
  • IPO Year
  • WVE 2015
  • THR 2011
  • Fundamental
  • Price
  • WVE $8.29
  • THR $25.56
  • Analyst Decision
  • WVE Strong Buy
  • THR
  • Analyst Count
  • WVE 17
  • THR 0
  • Target Price
  • WVE $19.94
  • THR N/A
  • AVG Volume (30 Days)
  • WVE 2.2M
  • THR 234.6K
  • Earning Date
  • WVE 07-30-2025
  • THR 11-06-2025
  • Dividend Yield
  • WVE N/A
  • THR N/A
  • EPS Growth
  • WVE N/A
  • THR 9.96
  • EPS
  • WVE N/A
  • THR 1.58
  • Revenue
  • WVE $93,946,000.00
  • THR $491,979,000.00
  • Revenue This Year
  • WVE N/A
  • THR $3.24
  • Revenue Next Year
  • WVE $10.02
  • THR $5.61
  • P/E Ratio
  • WVE N/A
  • THR $16.15
  • Revenue Growth
  • WVE N/A
  • THR N/A
  • 52 Week Low
  • WVE $5.04
  • THR $23.05
  • 52 Week High
  • WVE $16.74
  • THR $33.25
  • Technical
  • Relative Strength Index (RSI)
  • WVE 41.39
  • THR 44.42
  • Support Level
  • WVE $7.12
  • THR $25.40
  • Resistance Level
  • WVE $10.45
  • THR $27.12
  • Average True Range (ATR)
  • WVE 0.54
  • THR 0.80
  • MACD
  • WVE -0.24
  • THR 0.06
  • Stochastic Oscillator
  • WVE 33.82
  • THR 34.79

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About THR Thermon Group Holdings Inc.

Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.

Share on Social Networks: